Table 1.
Sociodemographic status and control of risk factors stratified by sex
| NTotal | Female | Male | P-value | |
|---|---|---|---|---|
| 1379 | 729 (52.9) | 650 (47.1) | ||
| Age group in years | 0.62 | |||
| 30–39 | 166 (12.0) | 82 (11.2) | 84 (12.9) | |
| 40–49 | 417 (30.2) | 226 (31.0) | 191 (29.4) | |
| 50–59 | 339 (24.6) | 185 (25.4) | 154 (23.7) | |
| 60–69 | 340 (24.7) | 180 (24.7) | 160 (24.6) | |
| 70–79 | 117 (8.5) | 56 (7.7) | 61 (9.4) | |
| Highest education in years | <0.001 | |||
| Primary (<10 yrs) | 331 (24.1) | 163 (22.4) | 168 (26.0) | |
| Secondary (10 yrs) | 411 (29.9) | 257 (35.3) | 154 (23.8) | |
| Tertiary (12 yrs) | 621 (45.2) | 301 (41.3) | 320 (49.5) | |
| Unclassified | 12 (0.9) | 7 (1.0) | 5 (0.8) | |
| Marital status | <0.001 | |||
| Single | 337 (24.5) | 177 (24.3) | 160 (24.7) | |
| Married | 811 (59.0) | 396 (54.4) | 415 (64.1) | |
| Divorced | 157 (11.4) | 104 (14.3) | 53 (8.2) | |
| Widowed | 70 (5.1) | 51 (7.0) | 19 (2.9) | |
| Household net income per month in Euro | <0.001 | |||
| <1500 | 168 (13.2) | 112 (16.9) | 56 (9.1) | |
| 1500 to <2900 | 458 (35.9) | 259 (20.3) | 199 (32.4) | |
| 2900 to <5000 | 421 (33.0) | 192 (29.0) | 229 (37.3) | |
| >5000 | 229 (17.9) | 99 (15.0) | 130 (21.2) | |
| BP a (mmHg) | ||||
| Systolic | 129.0 (118.0; 142.0) | 123.0 (113.0; 138.0) | 133.5 (123.0; 144.0) | <0.001 |
| Diastolic | 79.0 (72.5; 85.5) | 76.5 (70.5; 83.5) | 81.0 (75.5; 88.0) | <0.001 |
| High BP levels | ||||
| Self-reported hypertension | 546 (39.6) | 282 (38.7) | 264 (40.6) | 0.46 |
| BP ≥140/90 mmHg | 433 (31.8) | 177 (24.7) | 256 (39.6) | <0.001 |
| Unreported high BP above target | 156 (36.0) | 47 (26.6) | 109 (42.6) | 0.001 |
| Antihypertensive medication | 372 (27.0) | 197 (27.0) | 175 (27.0) | 0.90 |
| High BP level despite medicatione | 193 (52.7) | 94 (48.7) | 99 (57.2) | 0.12 |
| Diabetics treated with antihypertensive agents | 38 (67.9) | 17 (68.0) | 21 (67.7) | 0.98 |
| High BP level despite medicatione in diabetics | ||||
| Type 1 | 2 (5.6) | 1 (6.7) | 1 (4.8) | 0.76 |
| Type 2 | 16 (44.4) | 6 (40.0) | 10 (47.6) | 0.62 |
| Diabetes mellitus | ||||
| Self-reported diabetes | 79 (5.7) | 43 (5.9) | 36 (5.5) | 0.77 |
| HbA1c >6.5% | 46 (3.5) | 22 (3.2) | 24 (3.9) | 0.50 |
| Unreported DM above target | 13 (28.3) | 7 (31.8) | 6 (25.0) | 0.75 |
| Antidiabetic medication | 56 (4.1) | 25 (3.4) | 31 (4.8) | 0.20 |
| HbA1c ≥ 7% despite antidiabeticse | 22 (44.0) | 9 (39.1) | 13 (48.1) | 0.52 |
| LDL-cholesterol b (mg/dl) | 120.0 (100.0; 146.0) | 117.5 (96.8; 146.0) | 123.0 (105.5; 146.0) | <0.01 |
| High LDL-cholesterol levels | ||||
| Self-reported hyperlipidemia | 488 (35.4) | 247 (33.9) | 241 (37.1) | 0.22 |
| LDL-C >115 mg/dl | 753 (57.6) | 365 (52.9) | 388 (62.8) | <0.001 |
| Unreported high LDL-C levels above target | 408 (54.2) | 187 (51.2) | 221 (57.0) | 0.12 |
| Lipid-lowering agents | 112 (8.1) | 47 (6.4) | 65 (10.0) | 0.02 |
| High LDL-C level despite medicatione | 38 (37.3) | 18 (42.9) | 20 (33.3) | 0.33 |
| Lipid lowering treated diabetics | 22 (39.3) | 8 (32.0) | 14 (45.2) | 0.32 |
| High LDL-C level despite medicatione in diabetics | 4 (21.1) | 2 (28.6) | 2 (16.7) | 0.84 |
| Physically inactive | 323 (30.8) | 180 (33.1) | 143 (28.2) | 0.08 |
| Overweight | <0.001 | |||
| BMIc (kg/m2) | 25.5 (23.0; 28.9) | 24.7 (21.9; 28.5) | 26.3 (24.2; 29.1) | <0.001 |
| BMI > 25 kg/m2 | 751 (55.2) | 336 (46.7) | 415 (64.7) | <0.001 |
| BMI > 25 kg/m2 despite physical activity | 393 (54.9) | 162 (45.4) | 231 (64.3) | <0.001 |
| Current smoking | 266 (19.3) | 121 (16.6) | 145 (22.3) | <0.01 |
| Insufficiently controlled CV risk factors d | <0.001 | |||
| 0–2 | 639 (65.8) | 361 (72.3) | 278 (58.9) | |
| 3–6 | 322 (23.2) | 138 (27.7) | 194 (41.1) | |
Data are count (percent) or median (quartiles). Analyses are restricted to patients without missing values in respective variables.
aBlood pressure
bLow density lipoprotein- Cholesterol
cBody mass index
dCardiovascular risk factors
eProportion addressed at participant being treated